11(top 100%)
papers
537(top 50%)
citations
8(top 100%)
h-index
12(top 100%)
g-index
13
all documents
594
doc citations
236
citing journals
81
times ranked

Publications

13 papers • 594 citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant <i>Acinetobacter baumannii</i> infections
JAC-Antimicrobial Resistance, 2024, 6,
1.80Citations (PDF)
2Isolation and Characterization of Lytic Bacteriophages Targeting Diverse <i>Enterobacter</i> spp. Clinical Isolates
Phage, 2022, 3, 50-58
1.23Citations (PDF)
3Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance
MBio, 2022, 13,
4.546Citations (PDF)
4Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri
Antimicrobial Agents and Chemotherapy, 2021, 65,
4.313Citations (PDF)
5<i>In Vitro</i> Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirA
Microbiology Spectrum, 2021, 9,
3.636Citations (PDF)
6Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in <i>Enterobacter cloacae</i> Due to AmpC R2 Loop Deletion
Antimicrobial Agents and Chemotherapy, 2020, 64,
4.361Citations (PDF)
7High-Level Carbapenem Resistance in OXA-232-Producing Raoultella ornithinolytica Triggered by Ertapenem Therapy
Antimicrobial Agents and Chemotherapy, 2019, 64,
4.312Citations (PDF)
8Reduced ceftazidime and ertapenem susceptibility due to production of OXA-2 in Klebsiella pneumoniae ST258
Journal of Antimicrobial Chemotherapy, 2019, 74, 2203-2208
3.25Citations (PDF)
9636. Genome Epidemiology of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in the United States
Open Forum Infectious Diseases, 2019, 6, S295-S295
0.82Citations (PDF)
10Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward ‘molecularly targeted’ therapy
Expert Review of Anti-Infective Therapy, 2018, 16, 89-110
4.165Citations (PDF)
11Carbapenem-Resistant Enterobacteriaceae
Clinics in Laboratory Medicine, 2017, 37, 303-315
1.1169Citations (PDF)
12The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world
Journal of Travel Medicine, 2017, 24, S44-S51
2.7180Citations (PDF)
13Reduced Ertapenem Susceptibility Due to OXA-2 Production in Klebsiella pneumoniae ST258
Open Forum Infectious Diseases, 2017, 4, S128-S128
0.82Citations (PDF)